Atlas Trials

Natera, Inc.

36 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Natera, Inc.

RecordFirmDate
A Multicenter Randomized Open-Label Trial Evaluating ctDNA-Guided Interruption Versus Standard of Care Immune-Checkpoint Inhibitor (ICI) Therapy In Patients With Advanced / Metastatic Solid Tumors. (NCT07689812)Natera, Inc.2026-12-01
Signatera Assessment in Early-Stage Endometrial Cancer (NCT07339384)Natera, Inc.2026-10-01
Signatera-Guided De-escalation of Adjuvant Therapy in Resectable Stage II-IVa Gastric/Gastric-Esophageal Cancer (NCT07565857)Natera, Inc.2026-09-01
Sample Collection for Ongoing Research and Product Evaluation Study - Non-muscle Invasive Bladder Cancer (SCORE-NMIBC) (NCT07763197)Natera, Inc.2026-07-27
Sample Collection for Ongoing Research and Product Evaluation Study - Non-Hodgkin Lymphoma (SCORE-NHL) (NCT07750886)Natera, Inc.2026-07-27
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer (NCT07214532)Natera, Inc.2026-05-08
Sample Collection for Ongoing Research and Product Evaluation Study (NCT07318051)Natera, Inc.2025-07-21
A Comparative Effectiveness Study in Heart Transplant Patients of Rejection Surveillance With Cell-free DNA Versus Endomyocardial Biopsy (NCT06414603)Natera, Inc.2024-06-10
Prospective Collection of Samples to Enable the Development of Natera Screening Assay for Early Cancer Detection (NCT06620627)Natera, Inc.2024-01-26
EXpanding Prenatal Cell Free DNA Screening Across moNogenic Disorders (EXPAND) (NCT06808880)Natera, Inc.2024-01-25
Development of Non-invasive Cell-free DNA to Supplant Invasive Biopsy in Heart Transplantation (NCT05309382)Natera, Inc.2022-12-12
LAMBDA 002 (Lung Registry) Study (NCT05170425)Natera, Inc.2022-11-04
Prospera Test Evaluation in Cardiac Transplant (ProTECT) (NCT05205551)Natera, Inc.2021-10-01
Clinical Utility of the Addition of a SNP-based NIPT Zygosity Determination in Twin Pregnancy Management. (NCT05312814)Natera, Inc.2021-10-01
Verification of Risk Assignment for Whole Chromosome Using SNP-based NIPT in Vanishing Twin Pregnancies (NCT05004337)Natera, Inc.2021-07-22
BESPOKE Study of ctDNA Guided Immunotherapy (NCT04761783)Natera, Inc.2021-05-28
BESPOKE Study of ctDNA Guided Therapy in Colorectal Cancer (NCT04264702)Natera, Inc.2020-04-24
The PROspera Kidney Transplant ACTIVE Rejection Assessment Registry (ProActive) (NCT04091984)Natera, Inc.2019-11-06
Study for the Prediction of Active Rejection in Organs Using Donor-derived Cell-free DNA Detection (NCT03984747)Natera, Inc.2018-09-14
Natera Ovarian Cancer Detection Assay (NCT03485651)Natera, Inc.2017-12-14

Track Natera, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.